Trial Profile
Ranibizumab Exploratory Study on the Evaluation of the local laser combination therapy to non-reactive group to the diabetic macular edema patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2018
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 01 Oct 2018 Status changed from not yet recruiting to recruiting.
- 22 Nov 2016 New trial record